🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: High-throughput exome sequencing

Found 26 matching trials

Screening for Genes in Patients With Congenital Neutropenia

N/A

Syndromic congenital neutropenia (SCN) includes a heterogeneous group of di...

Status

Completed

Location

CHU Dijon Bourgogne

Start Date

2013-09

Trial ID

NCT02866162

Treatments Being Tested

High-throughput exome sequencing

Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study

N/A

Next Generation Sequencing in cancer: a feasibility study in France to asse...

Status

Completed

Location

Institut Bergonié

Start Date

2017-05-23

Trial ID

NCT03546127

Treatments Being Tested

Next Generation Sequencing (NGS): exome, RNA seq

Transcriptome and Metabolic Analyses of CHAPLE Disease

N/A

CHAPLE syndrome (complement hyperactivation, angiopathic thrombosis, protei...

Status

Unknown

Location

Marmara University

Start Date

2018-06-15

Trial ID

NCT03950804

Treatments Being Tested

Eculizumab Injection

Severe PID With Lymphoproliferation and Neutropenia

The purpose of this study is to analyse the phenotype in a sub-population o...

Status

Completed

Location

Service d'Immunologie Clinique et VIH - Hôpital Civil

Start Date

2018-03-13

Trial ID

NCT03427593

Treatments Being Tested

FACS analyses Target Sequencing by NGS ( Next-generation sequencing)Whole Exome Sequencing

Cancer Genome Analysis

N/A

Next generation sequencing (including targeted gene seqeuncing, exome and t...

Status

Unknown

Location

Seoul National University Hospital

Start Date

2011-08

Trial ID

NCT01458704

Treatments Being Tested

next generation sequencing

Evaluation of the Diagnostic Contribution of High-throughput Exome Sequencing for Patients With Convulsive Encephalopathy of Unknown Etiology: Pilot Study to Improve Genetic Counselling

N/A

Congenital epileptic encephalopathies (EE) are predominantly genetic in ori...

Status

Completed

Location

Chu Dijon Bourogne

Start Date

2013-09

Trial ID

NCT03652246

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

N/A

Novel treatment modalities like targeted therapies and Immune checkpoint in...

Status

Unknown

Location

European Institute of oncology

Start Date

2022-07-08

Trial ID

NCT06321640

Treatments Being Tested

Cohort A: primarily operable disease, candidate to adjuvant Cohort B: locally advanced disease Cohort C: metastatic disease Cohort D: Progressive disease Cohort E: Hematological neoplasms Cohort F: Toxicity

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing

Despite significant progress made in identification on numerous genes and g...

Status

Recruiting

Location

CHU Amiens Picardie

Start Date

2016-11-30

Trial ID

NCT03065686

Treatments Being Tested

identification of genetic factors

ANDDI-PRENATOME - Feasibility Study for a " Fast " Pangenomic High Throughput Sequencing Analysis in Prenatal Diagnosis

N/A

Prenatal diagnosis of genetic diseases is a real medical challenge. The dis...

Status

Completed

Location

CHU Dijon Bourgogne

Start Date

2019-06-20

Trial ID

NCT03964441

Treatments Being Tested

Invasive fetal sampling, blood sampling of mother and father blood sampling from the mother to recover the circulating cell free fetal DNA Parent interviews (optional organizational study)parent questionnaire (optional organizational study)professional interviews (optional organizational study)Focus group for professionals (optional organizational study)

Genetic Causes of Gestational Diabetes in the Emirati Population

N/A

The study aims to identify the number of MODY patients to be found among Em...

Status

Unknown

Location

Imperial College London Diabetes Centre

Start Date

2017-01-01

Trial ID

NCT03589092

Treatments Being Tested

Next generation sequencing (NGS)

Previous Next